Marzena Flasza-Baron
Services
Information
An overview of Cell and Gene Therapy Catapult capabilities includes:
1/ ATMP process development optimisation and scale up
2/ Analytical development and Process Analytical Technologies (PAT) enabling process digitalization
3/ High-throughput manufacturing automation and robotics
4/ Formulation (cryopreservation) and final fill-finish
5/ Establishing and optimisation of GMP manufacturing and supply chain
6/ Clinical adoption including CMC gap analysis, non-clinical safety, regulatory (MHRA, EMA, FDA), health economics and market access, pricing and reimbursement, clinical development including clinical trials design
